litlas
ログインアカウント作成

Tari A. King

1998–2025 年に発表

129
論文数
20,081
被引用数
59
h 指数
121
i10 指数

被引用数

Tari A. King の年別被引用数1997 年: 被引用 1 件1999 年: 被引用 4 件2000 年: 被引用 5 件2001 年: 被引用 5 件2002 年: 被引用 6 件2003 年: 被引用 10 件2004 年: 被引用 12 件2005 年: 被引用 11 件2006 年: 被引用 10 件2007 年: 被引用 11 件2008 年: 被引用 6 件2009 年: 被引用 5 件2010 年: 被引用 22 件2011 年: 被引用 26 件2012 年: 被引用 42 件2013 年: 被引用 75 件2014 年: 被引用 83 件2015 年: 被引用 113 件2016 年: 被引用 288 件2017 年: 被引用 390 件2018 年: 被引用 407 件2019 年: 被引用 919 件2020 年: 被引用 1,081 件2021 年: 被引用 1,107 件2022 年: 被引用 879 件2023 年: 被引用 700 件2024 年: 被引用 1,036 件2025 年: 被引用 526 件2026 年: 被引用 30 件1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,175 件、この内訳の 26%中国: 引用元論文 1,644 件、この内訳の 13.4%イギリス: 引用元論文 697 件、この内訳の 5.7%イタリア: 引用元論文 646 件、この内訳の 5.3%ドイツ: 引用元論文 546 件、この内訳の 4.5%オーストラリア: 引用元論文 374 件、この内訳の 3%スペイン: 引用元論文 373 件、この内訳の 3%オランダ: 引用元論文 367 件、この内訳の 3%カナダ: 引用元論文 365 件、この内訳の 3%フランス: 引用元論文 350 件、この内訳の 2.9%日本: 引用元論文 350 件、この内訳の 2.9%スイス: 引用元論文 266 件、この内訳の 2.2%
0%26%その他 25.1%

機関

分野

  • Biochemistry, Genetics and Molecular Biology61.3%
  • Medicine29.8%
  • Immunology and Microbiology5.3%
  • Computer Science0.9%
  • Engineering0.8%
  • Chemistry0.3%
  • その他1.6%

トピック

  • Extracellular vesicles in disease10.1%
  • MicroRNA in disease regulation6.5%
  • Breast Cancer Treatment Studies6.2%
  • Cancer Genomics and Diagnostics3.9%
  • Cancer Cells and Metastasis2.9%
  • HER2/EGFR in Cancer Research2.7%
  • その他67.7%

共著者

全論文

検索で開く
  1. Tumour exosome integrins determine organotropic metastasis

    著者: Ayuko Hoshino, Bruno Costa‐Silva, Tang‐Long Shen, Gonçalo Rodrigues, Ayako Hashimoto, Milica Tešić Mark, Henrik Molina, Shinji Kohsaka, Angela Di Giannatale, Sophia Ceder, Swarnima Singh, Caitlin Williams, Nadine Soplop, Kunihiro Uryu, Lindsay A. Pharmer, Tari A. King, Linda Bojmar, Alexander E. Davies, Yonathan Ararso, Tuo Zhang, Haiying Zhang, Jonathan M. Hernandez, Joshua M. Weiss, Vanessa D Dumont-Cole, Kimberly Kramer, Leonard H. Wexler, Aru Narendran, Gary K. Schwartz, John H. Healey, Per Sandström, Knut Jørgen Labori, Elin H. Kure, Paul M. Grandgenett, Michael A. Hollingsworth, Maria de Sousa, Sukhwinder Kaur, Maneesh Jain, Kavita Mallya, Surinder K. Batra, William R. Jarnagin, Mary S. Brady, Øystein Fodstad, Volkmar Muller, Klaus Pantel, Andy J. Minn, Mina J. Bissell, Benjamin A. García, Yibin Kang, Vinagolu K. Rajasekhar, Cyrus M. Ghajar, Irina Matei, Héctor Peinado, Jacqueline Bromberg, David Lyden - Nature 2015 被引用: 5,185

  2. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

    著者: Giovanni Ciriello, Michael L. Gatza, Andrew H. Beck, Matthew D. Wilkerson, Suhn K. Rhie, Alessandro Pastore, Hailei Zhang, Michael D. McLellan, Christina Yau, Cyriac Kandoth, Reanne Bowlby, Hui Shen, Sikander Hayat, Robert J. Fieldhouse, Susan C. Lester, Gary M. Tse, Rachel E. Factor, Laura C. Collins, Kimberly H. Allison, Yunn-Yi Chen, Kristin C. Jensen, Nicole B. Johnson, Steffi Oesterreich, Gordon B. Mills, Andrew D. Cherniack, Gordon Robertson, Christopher C. Benz, Chris Sander, Peter W. Laird, Katherine A. Hoadley, Tari A. King, Charles M. Perou, Rehan Akbani, J. Todd Auman, Miruna Balasundaram, Saianand Balu, Thomas Barr, Andrew H. Beck, Christopher C. Benz, Stephen C. Benz, Mario Berríos, Rameen Beroukhim, Tom Bodenheimer, Lori Boice, Lori Boice, Jay Bowen, Reanne Bowlby, Denise Brooks, Andrew D. Cherniack, Lynda Chin, Juok Cho, Sudha Chudamani, Giovanni Ciriello, Tanja M. Davidsen, John A. Demchok, Jennifer B. Dennison, Li Ding, Ina Felau, Martin L. Ferguson, Scott Frazer, Stacey Gabriel, Jianjiong Gao, Julie M. Gastier-Foster, Michael L. Gatza, Nils Gehlenborg, Mark Gerken, Gad Getz, William J. Gibson, D. Neil Hayes, David I. Heiman, Katherine A. Hoadley, Andrea Holbrook, Robert A. Holt, Alan P. Hoyle, Hai Hu, Mei Huang, Carolyn M. Hutter, E. Shelley Hwang, E. Shelley Hwang, Steven J.M. Jones, Zhenlin Ju, Jaegil Kim, Phillip H. Lai, Peter W. Laird, Michael S. Lawrence, Kristen M. Leraas, Tara M. Lichtenberg, Pei Lin, Shiyun Ling, Jia Liu, Wenbin Liu, Laxmi Lolla, Yiling Lu, Yussanne Ma, Dennis T. Maglinte, Elaine R. Mardis, Jeffrey R. Marks, Marco A. Marra, Cynthia McAllister, Michael D. McLellan ほか 60 名 - Cell 2015 被引用: 1,981

  3. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

    著者: Helen Davies, Dominik Głodzik, Sandro Morganella, Lucy Yates, Johan Staaf, Xueqing Zou, Manasa Ramakrishna, Sancha Martin, Sandrine Boyault, Anieta M. Sieuwerts, Peter T. Simpson, Tari A. King, Keiran Raine, Jórunn E. Eyfjörd, Gu Kong, Åke Borg, Ewan Birney, Hendrik G. Stunnenberg, Marc J. van de Vijver, Anne-Lise Børresen-Dale, John W.M. Martens, Paul N. Span, Sunil R. Lakhani, Anne Vincent‐Salomon, Christos Sotiriou, Andrew Tutt, Alastair M. Thompson, Steven Van Laere, Andrea L. Richardson, Alain Viari, Peter J. Campbell, Michael R. Stratton, Serena Nik‐Zainal - Nature Medicine 2017 被引用: 1,136

  4. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer

    著者: Weiyi Toy, Yang Shen, Helen Won, Bradley Green, Rita A. Sakr, Marie Will, Zhiqiang Li, Kinisha Gala, Sean W. Fanning, Tari A. King, Clifford A. Hudis, David Chen, Tetiana Taran, Gabriel N. Hortobágyi, Geoffrey L. Greene, Michael F. Berger, José Baselga, Sarat Chandarlapaty - Nature Genetics 2013 被引用: 1,259

  5. Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

    著者: Otto Metzger, Giuseppe Viale, Shayna Stein, Lorenzo Trippa, Denise A. Yardley, Ingrid A. Mayer, Vandana G. Abramson, Carlos L. Arteaga, Laura M. Spring, Adrienne G. Waks, Eileen Wrabel, Michelle K. DeMeo, Aditya Bardia, Patrizia Dell’Orto, Leila Russo, Tari A. King, Kornélia Polyák, Franziska Michor, Eric P. Winer, Ian E. Krop - Cancer Discovery 2021 被引用: 240

  6. Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung

    著者: Zvi Granot, Erik Henke, Elizabeth Comen, Tari A. King, Larry Norton, Robert Benezra - Cancer Cell 2011 被引用: 783

  7. Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer

    著者: Paolo Tarantino, Qingchun Jin, Nabihah Tayob, Rinath Jeselsohn, Stuart J. Schnitt, Julie Vincuilla, Tonia Parker, Svitlana Tyekucheva, Tianyu Li, Nancy U. Lin, Melissa E. Hughes, Anna Weiss, Tari A. King, Elizabeth A. Mittendorf, Giuseppe Curigliano, Sara M. Tolaney - JAMA Oncology 2022 被引用: 202

  8. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

    著者: Susana García‐Recio, Toshinori Hinoue, Gregory Wheeler, Benjamin Kelly, Ana C. Garrido-Castro, Tomás Pascual, Aguirre A. de Cubas, Youli Xia, Brooke Felsheim, Marni B. McClure, Andrei Rajkovic, Ezgi Karaesmen, Markia A. Smith, Cheng Fan, Paula I. González-Ericsson, Melinda E. Sanders, Chad J. Creighton, Jay Bowen, Kristen Leraas, Robyn Burns, Sara E. Coppens, Amy Wheless, Salma Rezk, Amy Garrett, Joel S. Parker, Kelly K. Foy, Hui Shen, Ben Ho Park, Ian E. Krop, Carey K. Anders, Julie M. Gastier‐Foster, Mothaffar F. Rimawi, Rita Nanda, Nancy U. Lin, Claudine Isaacs, P. Kelly Marcom, Anna Maria Storniolo, Fergus J. Couch, Uma Chandran, Michael A. Davis, Jonathan C. Silverstein, Alexander J. Ropelewski, Minetta C. Liu, Susan G. Hilsenbeck, Larry Norton, Andrea L. Richardson, W. Fraser Symmans, Antonio C. Wolff, Nancy E. Davidson, Lisa A. Carey, Adrian V. Lee, Justin M. Balko, Katherine A. Hoadley, Peter W. Laird, Elaine R. Mardis, Tari A. King, AURORA US Network, Aguirre A. de Cubas, Charles M. Perou - Nature Cancer 2022 被引用: 114

  9. Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline

    著者: Muriel Brackstone, Fulvia Baldassarre, Francisco Perera, Tulin Cil, Mariana Chávez‐MacGregor, Ian S. Dayes, Jay Engel, Janet K. Horton, Tari A. King, Anat Kornecki, Ralph George, Sandip Sengupta, Patricia A. Spears, Andrea Eisen - Journal of Clinical Oncology 2021 被引用: 287

  10. Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

    著者: Jennifer K. Litton, Meredith M. Regan, Lajos Pusztai, Hope S. Rugo, Sara M. Tolaney, Elizabeth Garrett‐Mayer, Laleh Amiri‐Kordestani, Reva Basho, Ana F. Best, Jean-François Boileau, Carsten Denkert, Jared C. Foster, Nadia Harbeck, Heather A. Jacene, Tari A. King, Ginny Mason, Ciara C. O’Sullivan, Tatiana M. Prowell, Andrea L. Richardson, Karla A. Sepulveda, Mary Lou Smith, Judy A. Tjoe, Gulisa Turashvili, Wendy A. Woodward, Lynn Pearson Butler, Elena I. Schwartz, Larissa A. Korde - Journal of Clinical Oncology 2023 被引用: 100

  11. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts

    著者: Siri H. Strand, Belén Rivero‐Gutiérrez, Kathleen E. Houlahan, José A. Seoane, Lorraine King, Tyler Risom, Lunden Simpson, Sujay Vennam, Aziz Khan, Luis Cisneros, Timothy Hardman, Bryan Harmon, Fergus J. Couch, Kristalyn K. Gallagher, Mark Kilgore, Wei Shi, Angela DeMichele, Tari A. King, Priscilla F. McAuliffe, Julie R. Nangia, Joanna Lee, Jennifer F. Tseng, Anna Maria Storniolo, Alastair M. Thompson, Gaorav P. Gupta, Robyn Burns, Deborah J. Veis, Katherine DeSchryver, Chunfang Zhu, Magdalena Matusiak, Jason Wang, Shirley Zhu, Jen Tappenden, Daisy Yi Ding, Dadong Zhang, Jingqin Luo, Shu Jiang, Sushama Varma, Lauren Anderson, Cody Straub, Sucheta Srivastava, Christina Curtis, Rob Tibshirani, Robert Michael Angelo, Allison Hall, Kouros Owzar, Kornélia Polyák, Carlo C. Maley, Jeffrey R. Marks, Graham A. Colditz, E. Shelley Hwang, Robert B. West - Cancer Cell 2022 被引用: 88

  12. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study

    著者: Anita Mamtani, Andrea V. Barrio, Tari A. King, Kimberly J. Van Zee, George Plitas, Melissa Pilewskie, Mahmoud El‐Tamer, Mary L. Gemignani, Alexandra S. Heerdt, Lisa M. Sclafani, Virgilio Sacchini, Hiram S. Cody, Sujata Patil, Monica Morrow - Annals of Surgical Oncology 2016 被引用: 309

  13. Progression from ductal carcinoma in situ to invasive breast cancer: Revisited

    著者: Catherine F. Cowell, Britta Weigelt, Rita A. Sakr, Charlotte K.Y. Ng, James Hicks, Tari A. King, Jorge S. Reis‐Filho - Molecular Oncology 2013 被引用: 254

  14. Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer

    著者: Sarat Chandarlapaty, Rita A. Sakr, Dilip D. Giri, Sujata Patil, Adriana Heguy, Monica Morrow, Shanu Modi, Larry Norton, Neal Rosen, Clifford A. Hudis, Tari A. King - Clinical Cancer Research 2012 被引用: 226

  15. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update

    著者: Neelima Denduluri, Mark R. Somerfield, Mariana Chávez‐MacGregor, Amy Comander, Zoneddy Dayao, Andrea Eisen, Rachel A. Freedman, Ragisha Gopalakrishnan, Stephanie L. Graff, Michael J. Hassett, Tari A. King, Gary H. Lyman, Gillian Rice Maupin, Raquel Nunes, Cheryl Perkins, Melinda L. Telli, Maureen Trudeau, Antonio C. Wolff, Sharon H. Giordano - Journal of Clinical Oncology 2020 被引用: 101

  16. De-escalating axillary surgery in early-stage breast cancer

    著者: Eliza H. Hersh, Tari A. King - The Breast 2021 被引用: 74

  17. Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast Cancer

    著者: Laura S. Dominici, Jiani Hu, Yue Zheng, Hee Jeong Kim, Tari A. King, Kathryn J. Ruddy, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Julia S. Wong, Ann H. Partridge, Shoshana M. Rosenberg - JAMA Surgery 2021 被引用: 54

  18. American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care

    著者: Nathan A. Pennell, Melissa S. Dillmon, Laura A. Levit, E. Allyn Moushey, Ajjai Alva, Sibel Blau, Timothy Lewis Cannon, Natalie R. Dickson, Maximilian Diehn, Mithat Gönen, Maria Magdalena González, Jack O. Hensold, Leslie Hinyard, Tari A. King, Stacie Lindsey, Allison Magnuson, Jonathan M. Marron, Barbara Mcaneny, Theresa Margaret McDonnell, Kathryn F. Mileham, S Nasso, Grzegorz S. Nowakowski, Kurt R. Oettel, Manali I. Patel, Debra A. Patt, Jane Perlmutter, Todd Pickard, Gladys Rodriguez, Abby R. Rosenberg, Barry Russo, Connie M. Szczepanek, Cardinale B. Smith, Piyush Srivastava, Eleonora Teplinsky, Ramya Thota, Tiffany A. Traina, Robin Zoň, Brian Bourbeau, Suanna S. Bruinooge, Shelagh E. Foster, Stephen Grubbs, Karen L. Hagerty, Patricia A. Hurley, Deborah Y. Kamin, Jonathan Phillips, Caroline Schenkel, Richard L. Schilsky, Howard A. Burris - Journal of Clinical Oncology 2020 被引用: 85

  19. Deep Learning vs Traditional Breast Cancer Risk Models to Support Risk-Based Mammography Screening

    著者: Constance D. Lehman, Sarah Mercaldo, Leslie R. Lamb, Tari A. King, Leif W. Ellisen, Michelle C. Specht, Rulla M. Tamimi - JNCI Journal of the National Cancer Institute 2022 被引用: 53

  20. A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer

    著者: Adrienne G. Waks, Neelam V. Desai, Tianyu Li, Philip D. Poorvu, Ann H. Partridge, Natalie Sinclair, Laura M. Spring, Meredith Faggen, Michael Constantine, Otto Metzger, Jillian Alberti, Julia Deane, Shoshana M. Rosenberg, Elizabeth Frank, Sara M. Tolaney, Ian E. Krop, Nadine Tung, Nabihah Tayob, Tari A. King, Elizabeth A. Mittendorf, Eric P. Winer - npj Breast Cancer 2022 被引用: 43

  21. Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer—Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update

    著者: Rachel A. Freedman, Jennifer L. Caswell‐Jin, Michael J. Hassett, Mark R. Somerfield, Sharon H. Giordano, for the Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer Guideline Expert Panel, Mariana Chávez‐MacGregor, Amy Comander, Zoneddy Dayao, Andrea Eisen, Rachel A. Freedman, Ragisha Gopalakrishnan, Stephanie L. Graff, Michael J. Hassett, Tari A. King, Gary H. Lyman, Gillian Rice Maupin, Cheryl Perkins, Melinda L. Telli, Maureen Trudeau, Antonio C. Wolff, Sharon H. Giordano - Journal of Clinical Oncology 2024 被引用: 32

  22. Contemporary Multi-Institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrates a Need for More Individualized Margin Guidelines

    著者: Laura H. Rosenberger, Samantha M. Thomas, Suniti Nimbkar, Tina J. Hieken, Kandice K. Ludwig, Lisa K. Jacobs, Megan E. Miller, Kristalyn K. Gallagher, Jasmine Wong, Heather B. Neuman, Jennifer Tseng, Taryn E. Hassinger, Tari A. King, James W. Jakub - Journal of Clinical Oncology 2020 被引用: 87

  23. Prevalence, Dynamics, and Prognostic Role of Clonal Hematopoiesis of Indeterminate Potential in Patients With Breast Cancer

    著者: Stefania Morganti, Christopher J. Gibson, Qingchun Jin, Katheryn Santos, Ashka Patel, Alex Wilson, Margaret S. Merrill, Julie Vincuilla, Samantha Stokes, Marla Lipsyc-Sharf, Tonia Parker, Tari A. King, Elizabeth A. Mittendorf, Giuseppe Curigliano, Melissa E. Hughes, Daniel G. Stover, Sara M. Tolaney, Lachelle D. Weeks, Nabihah Tayob, Nancy U. Lin, Judy E. Garber, Peter G. Miller, Heather A. Parsons - Journal of Clinical Oncology 2024 被引用: 33

  24. Presenting Features of Breast Cancer Differ by Molecular Subtype

    著者: L. Wiechmann, Michelle Sampson, Michelle Stempel, Lindsay M. Jacks, Sujata M. Patil, Tari A. King, Monica Morrow - Annals of Surgical Oncology 2009 被引用: 202